Mon. 13 May 2024, 9:03am ET
Benzinga
Biotech, General
A second site at a tertiary center in Boston, MA is expected to be activated in the next few weeks.
Proof-of-concept study for Imunon's first vaccine utilizing its proprietary PlaCCine platform is now open for enrollment